Lionel Tarassenko
Lionel Tarassenko | |
|---|---|
 | |
| Born | 17 April 1957 |
| Nationality | British |
| Alma mater | University of Oxford |
| Spouse | Dr Anne Tarassenko |
| Children | 3 children, 3 step-children |
| Awards |
|
| Scientific career | |
| Fields | Biomedical Engineering, Signal Processing, Machine Learning, Digital Health |
| Institutions | University of Oxford |
Lionel Tarassenko,
He was previously Head of Department of Engineering Science (Dean of Engineering) at the University of Oxford, succeeded by Ronald A. Roy.[5] Towards the end of his time as Dean, the Department rose to number 1 in the Times Higher Education World University Rankings.[6]
Tarassenko was elected Professor of Electrical Engineering at the
Tarassenko is the author of over 280 journal papers, 200 conference papers, 3 books and over 30 granted patents.[12] He has supervised 65 doctoral students. He has been a founder director of four University spin-out companies, the latest being Oxehealth in September 2012.[13] He was the R&D Director and Chair of the Strategic Advisory Board of Sensyne Health, an AIM-listed company from 2018 to 2022.[14] He is a director of the University’s wholly owned Technology Transfer company, Oxford University Innovation.[15] He was the editor-in-chief of the 2018 Topol Review of NHS Technology and its impact on the workforce.[16]
Tarassenko was the driving force behind the creation of the Institute of Biomedical Engineering (IBME) at the
Education
Tarassenko completed his BA in Engineering Science in 1978 at
Career and Research
Together with Professor Alan Murray of
Tarassenko then went on to develop methods for learning how to characterise normality in safety-critical systems. With his research team, he designed the QUICK system, which was at the core of Rolls-Royce’s engine health monitoring strategy in the 1990s and the early 2000s.[21][22] As a result, he and his Rolls-Royce collaborators were awarded the Chairman’s Team Award for Technical Innovation in 2001 and the Sir Henry Royce High Value Patent Award in 2008.
When he became the first Director of the Oxford Institute of Biomedical Engineering in 2008, Tarassenko focused his research on patient monitoring, both in and out of hospital. His work has had a major impact on the identification of deterioration in acute care and on the management of long-term conditions. He has been a pioneer in developing early warning systems for acutely ill patients. The machine-learning system (Visensia) which he designed for patient monitoring in critical care was the first such system to gain FDA approval (in 2008).[23]
In the last decade Tarassenko has led the engineering development of several digital health products including: (a) GDm-Health, a digital therapeutic for the management of gestational diabetes;[24] (b) SEND, a system for monitoring in-hospital patient vital signs and identifying deterioration early;[25][26](c) EDGE-COPD, a digital therapeutic for the self-monitoring and self-management of chronic obstructive pulmonary disease; and (d) Support-HF, a system for heart failure management in the community.
Tarassenko has been a founder director of four University spin-out companies, the latest being Oxehealth in September 2012.[27]
Awards and honours
Tarassenko was elected to a Fellowship of the
He was appointed a
Personal life
Tarassenko is married to Dr Anne Tarassenko. He has 3 children and 3 step-children. He is a Lay Canon of Christ Church Cathedral, Oxford.[29]
References
- ^ a b c EPSRC webpage
- ^ Royal Academy of Engineering News
- ^ a b Institute of Physics
- ^ Oxford Trust Outstanding Achievement Award
- ^ a b Andrew Ffrench (13 December 2018). "Oxford University is planning new graduate college". Oxford Mail.
- ^ Times Higher Education World University Rankings
- ^ The Brick: the newsletter for Keble alumni; Hilary term 2012, p. 3
- ^ St John's College, Oxford
- ^ "Parks College". University of Oxford.
- ^ University Officers
- ^ Management Committee of the Maison Française d’Oxford
- ^ Google Scholar
- ^ Oxehealth
- ^ Sensyne Health
- ^ At Oxford University Innovation Profile
- ^ Article in NHS Health Education England
- ^ Centre of Excellence in Medical Engineering, Institute of Biomedical Engineering, University of Oxford
- ^ NIHR Oxford Biomedical Research Centre
- ^ Queen's Anniversary Prize
- ^ Murray, A.F. and Tarassenko, L., 1994. Analogue neural VLSI: a pulse stream approach. Chapman & Hall, Ltd.
- ^ Nairac, A., Townsend, N., Carr, R., King, S., Cowley, P., and Tarassenko, L. A System for the Analysis of Jet Engine Vibration Data. Integr. Comput.-Aided Eng. 6, 1 (January 1999), 53-66.
- ^ Tarassenko, L., Clifton, D.A., Bannister, P.R., King, S., and King, D.: Novelty Detection. In: Worden, K., et al. (eds): Encyclopaedia of Structural Health Monitoring, Wiley, 2009
- ^ OBS Medical
- ^ GDm-Health on NHS Apps Library
- ^ SEND on NIHR Oxford BRC
- ^ Wong D, Bonnici T, Knight J, Morgan L, Coombes P, Watkinson P. SEND: a system for electronic notification and documentation of vital sign observations. BMC medical informatics and decision making. 2015 Dec;15(1):68.
- ^ Oxehealth
- ^ "List of Fellows".
- ^ "College of Canons and wider Chapter". Christ Church. University of Oxford. Retrieved 24 June 2019.
External links
- Oxford BioSignals Ltd (founding director)
- An Engineering Biography - Lionel Tarassenko FREng Ingenia, Issue 30, Mar 2007
- IdeasLab 2014 - Lionel Tarassenko - Self Monitoring Digital Health World Economic Forum, Davos, 2014
| Authority control databases: Academics |
|---|
